BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, Kastarinen M, Guessous I, Vinhas J, Stengel B, Brenner H, Chudek J, Romundstad S, Tomson C, Gonzalez AO, Bello AK, Ferrieres J, Palmieri L, Browne G, Capuano V, Van Biesen W, Zoccali C, Gansevoort R, Navis G, Rothenbacher D, Ferraro PM, Nitsch D, Wanner C, Jager KJ; European CKD Burden Consortium. CKD Prevalence Varies across the European General Population. J Am Soc Nephrol 2016;27:2135-47. [PMID: 26701975 DOI: 10.1681/ASN.2015050542] [Cited by in Crossref: 234] [Cited by in F6Publishing: 252] [Article Influence: 33.4] [Reference Citation Analysis]
Number Citing Articles
1 Law JP, Pickup L, Pavlovic D, Townend JN, Ferro CJ. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations. J Hum Hypertens 2022. [PMID: 36138105 DOI: 10.1038/s41371-022-00751-4] [Reference Citation Analysis]
2 Biebuyck GKM, Neradova A, de Fijter CWH, Jakulj L. Impact of telehealth interventions added to peritoneal dialysis-care: a systematic review. BMC Nephrol 2022;23:292. [PMID: 35999512 DOI: 10.1186/s12882-022-02869-6] [Reference Citation Analysis]
3 Fabian J, Kalyesubula R, Mkandawire J, Hansen CH, Nitsch D, Musenge E, Nakanga WP, Prynn JE, Dreyer G, Snyman T, Ssebunnya B, Ramsay M, Smeeth L, Tollman S, Naicker S, Crampin A, Newton R, George JA, Tomlinson L, Banda L, Bello S, Branson K, Chisambo C, Chithodwe O, Kanyenda C, Katundu C, Kayange N, Kayolo M, Kuchipanga V, Kyumba DM, Malunga A, Mvula B, Mweso E, Mwiba E, Ngwira L, Nkhwazi L, Thindwa M, Adams I, Barrow K, Beltramo C, Bouter C, Candy G, Chipungu S, Chitagu T, Dlamini P, Gomez Olive Casas X, Gondwe M, Gumede P, Kabudula C, Kagodora B, Kahn K, Khambule L, Khoza B, Khoza D, Khoza S, Khoza W, Levin J, Lesolang D, Mabuza M, Maher H, Mahime N, Malupi W, Maphatahanyi G, Mashaba N, Mathebula G, Mayindi B, Mdaka B, Mhembere M, Mkansi M, Mnisi R, Mnisi V, Mogane C, Mokoena T, Ndlovu W, Ndlovu Z, Ngobeni F, Ngobeni K, Ngobeni N, Ngobeni T, Ngwarai N, Nkuna D, Ntimane M, Ntimane T, Nxumalo O, Ohene-kwofie D, Sihlangu F, Silubane B, Soo C, Tibane J, Twine R, Ubisi S, Vangu M, Wade AN, Wafawanaka F, Asiki G, Bukenya D, Erone I, Tumwekase G, Kabunga E, Kakande A, Kaleebu P, Kamali A, Kiranda RA, Kushemererwa S, Kwizera M, Nabukenya KJ, Nakimera T, Naluggwa C, Nassimbwa S, Nyirenda M, Nabwato R, Makanga R, Seeley J, Sejjemba NE, Seremba G, Alumadri V, Bird N. Measurement of kidney function in Malawi, South Africa, and Uganda: a multicentre cohort study. The Lancet Global Health 2022;10:e1159-69. [DOI: 10.1016/s2214-109x(22)00239-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Stolpe S, Kowall B, Zwanziger D, Frank M, Jöckel KH, Erbel R, Stang A. External validation of six clinical models for prediction of chronic kidney disease in a German population. BMC Nephrol 2022;23:272. [PMID: 35915408 DOI: 10.1186/s12882-022-02899-0] [Reference Citation Analysis]
5 Liu XY, Zhang B, Cheng YX, Tao W, Yuan C, Wei ZQ, Peng D. Does chronic kidney disease affect the complications and prognosis of patients after primary colorectal cancer surgery? World J Gastrointest Oncol 2022; 14(6): 1199-1209 [DOI: 10.4251/wjgo.v14.i6.1199] [Reference Citation Analysis]
6 Sato R, Matsuzawa Y, Ogawa H, Kimura K, Tsuboi N, Yokoo T, Okada H, Konishi M, Kirigaya J, Fukui K, Tsukahara K, Shimizu H, Iwabuchi K, Yamada Y, Saka K, Takeuchi I, Kashihara N, Tamura K. Chronic kidney disease and clinical outcomes in patients with COVID-19 in Japan. Clin Exp Nephrol. [DOI: 10.1007/s10157-022-02240-x] [Reference Citation Analysis]
7 Ferraro PM, Agabiti N, Angelici L, Cascini S, Bargagli AM, Davoli M, Gambaro G, Marino C. Validation of a Classification Algorithm for Chronic Kidney Disease Based on Health Information Systems. J Clin Med 2022;11:2711. [PMID: 35628837 DOI: 10.3390/jcm11102711] [Reference Citation Analysis]
8 Wang J, Yin Y, Lu Q, Zhao Y, Hu Y, Hu Y, Wang Z, Wang F. Identification of Important Modules and Hub Gene in Chronic Kidney Disease Based on WGCNA. Journal of Immunology Research 2022;2022:1-12. [DOI: 10.1155/2022/4615292] [Reference Citation Analysis]
9 Cook S, Solbu MD, Eggen AE, Iakunchykova O, Averina M, Hopstock LA, Kholmatova K, Kudryavtsev AV, Leon DA, Malyutina S, Ryabikov A, Williamson E, Nitsch D. Comparing prevalence of chronic kidney disease and its risk factors between population-based surveys in Russia and Norway. BMC Nephrol 2022;23. [DOI: 10.1186/s12882-022-02738-2] [Reference Citation Analysis]
10 Eckes T, Patyna S, Koch A, Oftring A, Gauer S, Obermüller N, Schwalm S, Schaefer L, Chun J, Gröne H, Pfeilschifter J. Sphingosine 1-Phosphate Receptor 5 (S1P5) Knockout Ameliorates Adenine-Induced Nephropathy. IJMS 2022;23:3952. [DOI: 10.3390/ijms23073952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sawhney S, Bell S, Black C, Christiansen CF, Heide-jørgensen U, Jensen SK, Ronksley PE, Tan Z, Tonelli M, Walker H, James MT. Harmonization of epidemiology of acute kidney injury and acute kidney disease produces comparable findings across four geographic populations. Kidney International 2022. [DOI: 10.1016/j.kint.2022.02.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kalaitzidis RG, Theofilis P, Touchantzidou K, Vordoni A, Siamopoulos KC, Skapinakis P. Chronic Pain and Its Association with Depressive Symptoms and Renal Function in Hypertensive Patients. Int J Environ Res Public Health 2022;19:1899. [PMID: 35162927 DOI: 10.3390/ijerph19031899] [Reference Citation Analysis]
13 Li J, Ma L, Yu H, Yao Y, Xu Z, Lin W, Wang L, Wang X, Yang H. MicroRNAs as Potential Biomarkers for the Diagnosis of Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Front Med 2022;8:782561. [DOI: 10.3389/fmed.2021.782561] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Zhang D, Chen S, Gao M, Lin Y, Hong F, You Z, Chen X, Wu S. Ultrasound-Guided Radiofrequency Ablation: A New Attempt to the Treatment of Refractory Hyperparathyroidism Secondary to Chronic Kidney Disease. Kidney International Reports 2022;7:282-8. [DOI: 10.1016/j.ekir.2021.11.038] [Reference Citation Analysis]
15 Miroski de Abreu A, Copetti CLK, Hauschild DB, Di Pietro PF, Wazlawik E. Effects of supplementation with vegetable sources of alpha-linolenic acid (ALA) on inflammatory markers and lipid profile in individuals with chronic kidney disease: A systematic review and meta-analysis. Clinical Nutrition 2022. [DOI: 10.1016/j.clnu.2022.02.013] [Reference Citation Analysis]
16 Winitzki D, Zacharias HU, Nadal J, Baid-agrawal S, Schaeffner E, Schmid M, Busch M, Bergmann MM, Schultheiss U, Kotsis F, Stockmann H, Meiselbach H, Wolf G, Krane V, Sommerer C, Eckardt K, Schneider MP, Schlieper G, Floege J, Saritas T. Educational Attainment Is Associated With Kidney and Cardiovascular Outcomes in CKD. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.02.001] [Reference Citation Analysis]
17 Yasuzawa T, Nakamura T, Ueshima S, Mima A. Protective Effects of Eicosapentaenoic Acid on the Glomerular Endothelium via Inhibition of EndMT in Diabetes. J Diabetes Res 2021;2021:2182225. [PMID: 34977254 DOI: 10.1155/2021/2182225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Mendoza-pitti L, Gomez-pulido JM, Vargas-lombardo M, Gomez-pulido JA, Polo-luque M, Rodriguez-puyol D. Machine-Learning Model to Predict the Intradialytic Hypotension Based on Clinical-Analytical Data. IEEE Access 2022;10:72065-79. [DOI: 10.1109/access.2022.3189018] [Reference Citation Analysis]
19 Shi Y, Jin X, Yang M, Jia J, Yao H, Yuan W, Wang K, Rong S. CKAP4 contributes to the progression of vascular calcification (VC) in chronic kidney disease (CKD) by modulating YAP phosphorylation and MMP2 expression. Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110270] [Reference Citation Analysis]
20 Major RW, Shepherd D, Medcalf JF, Xu G, Gray LJ, Brunskill NJ. Comorbidities and outcomes in South Asian individuals with chronic kidney disease: an observational primary care cohort. Nephrol Dial Transplant 2021;37:108-14. [PMID: 33439998 DOI: 10.1093/ndt/gfaa291] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Hirst JA, Taal M, Fraser SD, Ordóñez-Mena J, O'Callaghan C, McManus R, Taylor C, Yang Y, Ogburn E, Hobbs FR. Change in GFR over time in the Oxford Renal Cohort Study. Br J Gen Pract 2021:BJGP. [PMID: 34990394 DOI: 10.3399/BJGP.2021.0477] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Jin D, Lin L, Xie Y, Jia M, Qiu H, Xun K. NRF2-suppressed vascular calcification by regulating the antioxidant pathway in chronic kidney disease. FASEB J 2022;36:e22098. [PMID: 34918390 DOI: 10.1096/fj.202100625RR] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
23 Krata N, Foroncewicz B, Zagożdżon R, Moszczuk B, Zielenkiewicz M, Pączek L, Mucha K. Peroxiredoxins as Markers of Oxidative Stress in IgA Nephropathy, Membranous Nephropathy and Lupus Nephritis. Arch Immunol Ther Exp (Warsz) 2021;70:3. [PMID: 34914001 DOI: 10.1007/s00005-021-00638-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
24 Nasir K, Qureshi R, Qureshi H, Dhrolia M, Ahmad A. Bone Marrow Findings in Renal Patients: A Single Renal Specialist Center Experience. Cureus 2021;13:e18912. [PMID: 34812298 DOI: 10.7759/cureus.18912] [Reference Citation Analysis]
25 Stolpe S, Kowall B, Scholz C, Stang A, Blume C. High Unawareness of Chronic Kidney Disease in Germany. Int J Environ Res Public Health 2021;18:11752. [PMID: 34831506 DOI: 10.3390/ijerph182211752] [Reference Citation Analysis]
26 Escobar C, Aranda U, Palacios B, Capel M, Sicras A, Sicras A, Hormigo A, Alcázar R, Manito N, Botana M. Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain. Nefrología (English Edition) 2021;41:670-88. [DOI: 10.1016/j.nefroe.2022.01.008] [Reference Citation Analysis]
27 de Kort BJ, Koch SE, Wissing TB, Krebber MM, Bouten CVC, Smits AIPM. Immuno-regenerative biomaterials for in situ cardiovascular tissue engineering - Do patient characteristics warrant precision engineering? Adv Drug Deliv Rev 2021;178:113960. [PMID: 34481036 DOI: 10.1016/j.addr.2021.113960] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
28 Haase A, Stracke S, Chenot JF, Weckmann G. [Perspective of General Practitioners on Management of Non-dialysis Chronic Kidney Disease - a Qualitative Study]. Dtsch Med Wochenschr 2021;146:e97-e102. [PMID: 34704237 DOI: 10.1055/a-1582-0130] [Reference Citation Analysis]
29 Olié V, Cheddani L, Stengel B, Gabet A, Grave C, Blacher J, Halimi JM. [Prevalence of chronic kidney disease in France, Esteban study 2014-2016]. Nephrol Ther 2021;17:526-31. [PMID: 34629319 DOI: 10.1016/j.nephro.2021.05.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Piscitelli P, D'Errico MM, Mirijello A, Santoliquido M, Salvatori M, Vigna C, Marchese N, Vendemiale G, Copetti M, Pontremoli R, De Cosmo SA. Low GFR amplifies the association between coronary three-vessel disease and all-cause mortality. Nutr Metab Cardiovasc Dis 2021:S0939-4753(21)00496-8. [PMID: 34893408 DOI: 10.1016/j.numecd.2021.09.036] [Reference Citation Analysis]
31 Harambat J, Madden I, Hogan J. [Epidemiology of pediatric chronic kidney disease]. Nephrol Ther 2021;17:476-84. [PMID: 34518130 DOI: 10.1016/j.nephro.2021.06.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Foudi N, Palayer M, Briet M, Garnier AS. Arterial Remodelling in Chronic Kidney Disease: Impact of Uraemic Toxins and New Pharmacological Approaches. J Clin Med 2021;10:3803. [PMID: 34501251 DOI: 10.3390/jcm10173803] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Kao CC, Wang SY, Chuang YK, Lee WY, Chang WC, Wu MS, Kuo TC, Tsai IL. Clinical Mass Spectrometry Discovered Human IgG Sialylation as a Potential Biosignature for Kidney Function. J Pers Med 2021;11:761. [PMID: 34442405 DOI: 10.3390/jpm11080761] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Nguyen-Thi HY, Le-Phuoc TN, Tri Phat N, Truong Van D, Le-Thi TT, Le NDT, Tran-Thi HN, Pham Dinh L. The Economic Burden of Chronic Kidney Disease in Vietnam. Health Serv Insights 2021;14:11786329211036011. [PMID: 34376990 DOI: 10.1177/11786329211036011] [Reference Citation Analysis]
35 Marcel S, Remus PA. Association Between Classical and Emerging Risk Factors for Diabetic Kidney Disease and Albuminuria in a Cohort of Type 2 Diabetes Mellitus Patients. Internal Medicine 2021;18:17-25. [DOI: 10.2478/inmed-2021-0163] [Reference Citation Analysis]
36 Galanter W, Rodríguez-Fernández JM, Chow K, Harford S, Kochendorfer KM, Pishgar M, Theis J, Zulueta J, Darabi H. Predicting clinical outcomes among hospitalized COVID-19 patients using both local and published models. BMC Med Inform Decis Mak 2021;21:224. [PMID: 34303356 DOI: 10.1186/s12911-021-01576-w] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
37 Chandrasekaran V, Carta G, da Costa Pereira D, Gupta R, Murphy C, Feifel E, Kern G, Lechner J, Cavallo AL, Gupta S, Caiment F, Kleinjans JCS, Gstraunthaler G, Jennings P, Wilmes A. Generation and characterization of iPSC-derived renal proximal tubule-like cells with extended stability. Sci Rep 2021;11:11575. [PMID: 34078926 DOI: 10.1038/s41598-021-89550-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
38 Escobar C, Palacios B, Aranda U, Capel M, Sicras A, Sicras A, Hormigo A, Alcázar R, Manito N, Botana M. Costs and healthcare utilisation of patients with chronic kidney disease in Spain. BMC Health Serv Res 2021;21:536. [PMID: 34074269 DOI: 10.1186/s12913-021-06566-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Engelbertz C, Pinnschmidt HO, Freisinger E, Reinecke H, Schmitz B, Fobker M, Schmieder RE, Wegscheider K, Breithardt G, Pavenstädt H, Brand E. Sex-specific differences and long-term outcome of patients with coronary artery disease and chronic kidney disease: the Coronary Artery Disease and Renal Failure (CAD-REF) Registry. Clin Res Cardiol 2021. [PMID: 34036426 DOI: 10.1007/s00392-021-01864-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Filipska A, Bohdan B, Wieczorek PP, Hudz N. Chronic kidney disease and dialysis therapy: incidence and prevalence in the world. PHAR 2021;68:463-70. [DOI: 10.3897/pharmacia.68.e65501] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Bover J, Aguilar A, Arana C, Molina P, Lloret MJ, Ochoa J, Berná G, Gutiérrez-Maza YG, Rodrigues N, D'Marco L, Górriz JL. Clinical Approach to Vascular Calcification in Patients With Non-dialysis Dependent Chronic Kidney Disease: Mineral-Bone Disorder-Related Aspects. Front Med (Lausanne) 2021;8:642718. [PMID: 34095165 DOI: 10.3389/fmed.2021.642718] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
42 Yu J, Song Y, Yang A, Zhang X, Li L. Serum nuclear factor IB as a novel and noninvasive indicator in the diagnosis of secondary hyperparathyroidism. J Clin Lab Anal 2021;35:e23787. [PMID: 33991027 DOI: 10.1002/jcla.23787] [Reference Citation Analysis]
43 Rashed-Al-Mahfuz M, Haque A, Azad A, Alyami SA, Quinn JMW, Moni MA. Clinically Applicable Machine Learning Approaches to Identify Attributes of Chronic Kidney Disease (CKD) for Use in Low-Cost Diagnostic Screening. IEEE J Transl Eng Health Med 2021;9:4900511. [PMID: 33948393 DOI: 10.1109/JTEHM.2021.3073629] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Alfieri CM, Molinari P, Gandolfo M, Campise M, Cresseri D, Regalia A, Favi E, Li M, Ikehata M, Delbue S, Messa P. Cytomegalovirus Disease in Renal Transplanted Patients: Prevalence, Determining Factors, and Influence on Graft and Patients Outcomes. Pathogens 2021;10:473. [PMID: 33919676 DOI: 10.3390/pathogens10040473] [Reference Citation Analysis]
45 Kelly DM, Anders HJ, Bello AK, Choukroun G, Coppo R, Dreyer G, Eckardt KU, Johnson DW, Jha V, Harris DCH, Levin A, Lunney M, Luyckx V, Marti HP, Messa P, Mueller TF, Saad S, Stengel B, Vanholder RC, Weinstein T, Khan M, Zaidi D, Osman MA, Ye F, Tonelli M, Okpechi IG, Rondeau E; ISN Western Europe Regional Board. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western Europe. Kidney Int Suppl (2011) 2021;11:e106-18. [PMID: 33981476 DOI: 10.1016/j.kisu.2021.01.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Fritz J, Brozek W, Concin H, Nagel G, Kerschbaum J, Lhotta K, Ulmer H, Zitt E. The Triglyceride-Glucose Index and Obesity-Related Risk of End-Stage Kidney Disease in Austrian Adults. JAMA Netw Open 2021;4:e212612. [PMID: 33787913 DOI: 10.1001/jamanetworkopen.2021.2612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
47 Vallejo-Valdivieso PA, Zambrano-Pincay G, Ortiz A. Undiagnosed cardiovascular risk factors in overweight and obese individuals: a low income country experience. PeerJ 2021;9:e10870. [PMID: 33604197 DOI: 10.7717/peerj.10870] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Lopau K, Wanner C. Treatment rationale for coronary heart disease in advanced CKD. Herz 2021;46:221-7. [PMID: 33566140 DOI: 10.1007/s00059-021-05025-2] [Reference Citation Analysis]
49 Voigt P, Kairys P, Voigt A, Frese T. [Non-dialysis chronic kidney disease in primary care - a questionnaire study among general practitioners]. Dtsch Med Wochenschr 2021;146:e39-46. [PMID: 33477172 DOI: 10.1055/a-1334-2513] [Reference Citation Analysis]
50 Hamroun A, Camier A, Bigna JJ, Glowacki F. Impact of air pollution on renal outcomes: a systematic review and meta-analysis protocol. BMJ Open 2021;11:e041088. [PMID: 33455930 DOI: 10.1136/bmjopen-2020-041088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Hirst JA, Ordóñez Mena JM, O'Callaghan CA, Ogburn E, Taylor CJ, Yang Y, Hobbs FDR. Prevalence and factors associated with multimorbidity among primary care patients with decreased renal function. PLoS One 2021;16:e0245131. [PMID: 33449936 DOI: 10.1371/journal.pone.0245131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Häckl D, Kossack N, Schoenfelder T. [Prevalence, Costs of Medical Treatment and Modalities of Dialysis-dependent Chronic Renal Failure in Germany: Comparison of Dialysis Care of Nursing Home Residents and in Outpatient Units]. Gesundheitswesen 2021;83:818-28. [PMID: 33450773 DOI: 10.1055/a-1330-7152] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Polychronopoulou E, Wuerzner G, Burnier M. How Do I Manage Hypertension in Patients with Advanced Chronic Kidney Disease Not on Dialysis? Perspectives from Clinical Practice. Vasc Health Risk Manag 2021;17:1-11. [PMID: 33442257 DOI: 10.2147/VHRM.S292522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Batiushin MM. Chronic Kidney Disease: Current State of the Problem. Racionalʹnaâ farmakoterapiâ v kardiologii 2020;16:938-47. [DOI: 10.20996/1819-6446-2020-11-06] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
55 Rapattoni W, Zante D, Tomas M, Myageri V, Golden S, Grover P, Tehrani A, Millson B, Tobe SW, Rose JB. A retrospective observational population-based study to assess the prevalence and burden of illness of type 2 diabetes with an estimated glomerular filtration rate < 90 mL/min/1.73 m2 in Ontario, Canada. Diabetes Obes Metab 2021;23:916-28. [PMID: 33319487 DOI: 10.1111/dom.14294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Heras Benito M, Fernández-Reyes Luis MJ, Martín Varas C, Urzola Rodríguez G. [Clinical characteristics of chronic kidney disease (no dialysis) in nonagenarians]. Rev Esp Geriatr Gerontol 2021;56:119-20. [PMID: 33303256 DOI: 10.1016/j.regg.2020.10.006] [Reference Citation Analysis]
57 van Rijn MHC, Alencar de Pinho N, Wetzels JF, van den Brand JAJG, Stengel B. Worldwide Disparity in the Relation Between CKD Prevalence and Kidney Failure Risk. Kidney Int Rep 2020;5:2284-91. [PMID: 33305122 DOI: 10.1016/j.ekir.2020.09.040] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
58 Hao J, Tang J, Zhang L, Li X, Hao L. The Crosstalk between Calcium Ions and Aldosterone Contributes to Inflammation, Apoptosis, and Calcification of VSMC via the AIF-1/NF-κB Pathway in Uremia. Oxid Med Cell Longev 2020;2020:3431597. [PMID: 33343805 DOI: 10.1155/2020/3431597] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
59 Reichel H, Zee J, Tu C, Young E, Pisoni RL, Stengel B, Duttlinger J, Lonnemann G, Robinson BM, Pecoits-Filho R, Fliser D. Chronic kidney disease progression and mortality risk profiles in Germany: results from the Chronic Kidney Disease Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2020;35:803-10. [PMID: 31953939 DOI: 10.1093/ndt/gfz260] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
60 Rothenbacher D, Rehm M, Iacoviello L, Costanzo S, Tunstall-Pedoe H, Belch JJF, Söderberg S, Hultdin J, Salomaa V, Jousilahti P, Linneberg A, Sans S, Padró T, Thorand B, Meisinger C, Kee F, McKnight AJ, Palosaari T, Kuulasmaa K, Waldeyer C, Zeller T, Blankenberg S, Koenig W; BiomarCaRE consortium. Contribution of cystatin C- and creatinine-based definitions of chronic kidney disease to cardiovascular risk assessment in 20 population-based and 3 disease cohorts: the BiomarCaRE project. BMC Med 2020;18:300. [PMID: 33161898 DOI: 10.1186/s12916-020-01776-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
61 van Oosten MJM, Brohet RM, Logtenberg SJJ, Kramer A, Dikkeschei LD, Hemmelder MH, Bilo HJG, Jager KJ, Stel VS. The validity of Dutch health claims data for identifying patients with chronic kidney disease: a hospital-based study in the Netherlands. Clin Kidney J 2021;14:1586-93. [PMID: 34276977 DOI: 10.1093/ckj/sfaa167] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Michna M, Kovarova L, Valerianova A, Malikova H, Weichet J, Malik J. Review of the structural and functional brain changes associated with chronic kidney disease. Physiol Res 2020;69:1013-28. [PMID: 33129242 DOI: 10.33549/physiolres.934420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
63 De Broe M, Delanaye P. How to interpret an estimated glomerular filtration rate (eGFR) in 2020? Kidney Int 2020;98:1090-2. [PMID: 33126972 DOI: 10.1016/j.kint.2020.07.015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Weckmann G, Chenot JF, Stracke S. The Management of Non-Dialysis-Dependent Chronic Kidney Disease in Primary Care. Dtsch Arztebl Int 2020;117:745-51. [PMID: 33439824 DOI: 10.3238/arztebl.2020.0745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Gao C, Tomaniak M, Takahashi K, Kawashima H, Wang R, Hara H, Ono M, Montalescot G, Garg S, Haude M, Slagboom T, Vranckx P, Valgimigli M, Windecker S, van Geuns RJ, Hamm C, Steg PG, Onuma Y, Angiolillo DJ, Serruys PW. Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial. Cardiovasc Diabetol 2020;19:179. [PMID: 33066794 DOI: 10.1186/s12933-020-01153-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
66 Brandi ML, Giustina A. Sexual Dimorphism of Coronavirus 19 Morbidity and Lethality. Trends Endocrinol Metab 2020;31:918-27. [PMID: 33082024 DOI: 10.1016/j.tem.2020.09.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
67 Lye WK, Paterson E, Patterson CC, Maxwell AP, Binte Mohammed Abdul RB, Tai ES, Cheng CY, Kayama T, Yamashita H, Sarnak M, Shlipak M, Matsushita K, Mutlu U, Ikram MA, Klaver C, Kifley A, Mitchell P, Myers C, Klein BE, Klein R, Wong TY, Sabanayagam C, McKay GJ. A systematic review and participant-level meta-analysis found little association of retinal microvascular caliber with reduced kidney function. Kidney Int 2021;99:696-706. [PMID: 32810524 DOI: 10.1016/j.kint.2020.06.033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
68 Ji C, Deng Y, Yang A, Lu Z, Chen Y, Liu X, Han L, Zou C. Rhubarb Enema Improved Colon Mucosal Barrier Injury in 5/6 Nephrectomy Rats May Associate With Gut Microbiota Modification. Front Pharmacol 2020;11:1092. [PMID: 32848732 DOI: 10.3389/fphar.2020.01092] [Cited by in Crossref: 5] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
69 Franchi F, James SK, Ghukasyan Lakic T, Budaj AJ, Cornel JH, Katus HA, Keltai M, Kontny F, Lewis BS, Storey RF, Himmelmann A, Wallentin L, Angiolillo DJ; PLATO Investigators. Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y12 Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial. J Am Heart Assoc 2019;8:e011139. [PMID: 30857464 DOI: 10.1161/JAHA.118.011139] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
70 Marzullo P, Di Renzo L, Pugliese G, De Siena M, Barrea L, Muscogiuri G, Colao A, Savastano S; Obesity Programs of nutrition, Education, Research and Assessment (OPERA) Group. From obesity through gut microbiota to cardiovascular diseases: a dangerous journey. Int J Obes Suppl 2020;10:35-49. [PMID: 32714511 DOI: 10.1038/s41367-020-0017-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
71 Noce A, Bocedi A, Campo M, Marrone G, Di Lauro M, Cattani G, Di Daniele N, Romani A. A Pilot Study of a Natural Food Supplement as New Possible Therapeutic Approach in Chronic Kidney Disease Patients. Pharmaceuticals (Basel) 2020;13:E148. [PMID: 32664308 DOI: 10.3390/ph13070148] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
72 Bosdriesz JR, Stel VS, van Diepen M, Meuleman Y, Dekker FW, Zoccali C, Jager KJ. Evidence-based medicine-When observational studies are better than randomized controlled trials. Nephrology (Carlton) 2020;25:737-43. [PMID: 32542836 DOI: 10.1111/nep.13742] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
73 Chen X, Liu Y, Wang J, Zhao J, Singh N, Zhang WW. A systematic review and meta-analysis of the risk of death and patency after application of paclitaxel-coated balloons in the hemodialysis access. J Vasc Surg 2020;72:2186-2196.e3. [PMID: 32540324 DOI: 10.1016/j.jvs.2020.04.525] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
74 Masimango MI, Sumaili EK, Wallemacq P, Malembaka EB, Hermans MP, Fillée C, D'Hoore W, Winkler CA, Limou S, Jadoul M. Prevalence and Risk Factors of CKD in South Kivu, Democratic Republic of Congo: A Large-Scale Population Study. Kidney Int Rep 2020;5:1251-60. [PMID: 32775824 DOI: 10.1016/j.ekir.2020.05.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
75 Eriksen BO, Palsson R, Ebert N, Melsom T, van der Giet M, Gudnason V, Indridason OS, Inker LA, Jenssen TG, Levey AS, Solbu MD, Tighiouart H, Schaeffner E. GFR in Healthy Aging: an Individual Participant Data Meta-Analysis of Iohexol Clearance in European Population-Based Cohorts. J Am Soc Nephrol 2020;31:1602-15. [PMID: 32499396 DOI: 10.1681/ASN.2020020151] [Cited by in Crossref: 10] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
76 Birkeland KI, Bodegard J, Eriksson JW, Norhammar A, Haller H, Linssen GCM, Banerjee A, Thuresson M, Okami S, Garal-Pantaler E, Overbeek J, Mamza JB, Zhang R, Yajima T, Komuro I, Kadowaki T. Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study. Diabetes Obes Metab 2020;22:1607-18. [PMID: 32363737 DOI: 10.1111/dom.14074] [Cited by in Crossref: 24] [Cited by in F6Publishing: 42] [Article Influence: 12.0] [Reference Citation Analysis]
77 Malmgren L, McGuigan FE, Christensson A, Akesson KE. Longitudinal Changes in Kidney Function Estimated from Cystatin C and Its Association with Mortality in Elderly Women. Nephron 2020;144:290-8. [PMID: 32392561 DOI: 10.1159/000507256] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
78 Chang HJ, Lin KR, Lin MT, Chang JL. Association between lifestyle factors and decreased kidney function in older adults: a community-based cross-sectional analysis of the Taipei City elderly health examination database. BMC Nephrol 2020;21:169. [PMID: 32384928 DOI: 10.1186/s12882-020-01838-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
79 Papandreou C, Moré M, Bellamine A. Trimethylamine N-Oxide in Relation to Cardiometabolic Health-Cause or Effect? Nutrients 2020;12:E1330. [PMID: 32392758 DOI: 10.3390/nu12051330] [Cited by in Crossref: 28] [Cited by in F6Publishing: 42] [Article Influence: 14.0] [Reference Citation Analysis]
80 Van den Bulck SA, Vankrunkelsven P, Goderis G, Van Pottelbergh G, Swerts J, Panis K, Hermens R. Developing quality indicators for Chronic Kidney Disease in primary care, extractable from the Electronic Medical Record. A Rand-modified Delphi method. BMC Nephrol 2020;21:161. [PMID: 32370742 DOI: 10.1186/s12882-020-01788-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
81 Barbieri MA, Rottura M, Cicala G, Mandraffino R, Marino S, Irrera N, Mannucci C, Santoro D, Squadrito F, Arcoraci V. Chronic Kidney Disease Management in General Practice: A Focus on Inappropriate Drugs Prescriptions. J Clin Med 2020;9:E1346. [PMID: 32375415 DOI: 10.3390/jcm9051346] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
82 Steubl D, Schneider MP, Meiselbach H, Nadal J, Schmid MC, Saritas T, Krane V, Sommerer C, Baid-Agrawal S, Voelkl J, Kotsis F, Köttgen A, Eckardt KU, Scherberich JE; GCKD Study Investigators. Association of Serum Uromodulin with Death, Cardiovascular Events, and Kidney Failure in CKD. Clin J Am Soc Nephrol 2020;15:616-24. [PMID: 32291270 DOI: 10.2215/CJN.11780919] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
83 Molina-Andújar A, Robles P, Cibeira MT, Montagud-Marrahi E, Guillen E, Xipell M, Blasco M, Poch E, Rosiñol L, Bladé J, Quintana LF. The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease. BMC Nephrol 2020;21:111. [PMID: 32234026 DOI: 10.1186/s12882-020-01771-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
84 Law JP, Price AM, Pickup L, Radhakrishnan A, Weston C, Jones AM, McGettrick HM, Chua W, Steeds RP, Fabritz L, Kirchhof P, Pavlovic D, Townend JN, Ferro CJ. Clinical Potential of Targeting Fibroblast Growth Factor-23 and αKlotho in the Treatment of Uremic Cardiomyopathy. J Am Heart Assoc 2020;9:e016041. [PMID: 32212912 DOI: 10.1161/JAHA.120.016041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
85 Hirst JA, Hill N, O'Callaghan CA, Lasserson D, McManus RJ, Ogburn E, Mena JMO, Shine B, Taylor CJ, Vazquez-Montes MD, Yang Y, Hobbs FR. Prevalence of chronic kidney disease in the community using data from OxRen: a UK population-based cohort study. Br J Gen Pract 2020;70:e285-93. [PMID: 32041766 DOI: 10.3399/bjgp20X708245] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
86 Ishiuchi N, Nakashima A, Doi S, Yoshida K, Maeda S, Kanai R, Yamada Y, Ike T, Doi T, Kato Y, Masaki T. Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats. Stem Cell Res Ther 2020;11:130. [PMID: 32197638 DOI: 10.1186/s13287-020-01642-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
87 Wu D, Bai J, Cui S, Fu B, Yin Z, Cai G, Chen X. Renal progenitor cells modulated by angiotensin II receptor blocker (ARB) medication and differentiation towards podocytes in anti-thy1.1 nephritis. Ann Transl Med 2020;8:355. [PMID: 32355799 DOI: 10.21037/atm.2020.02.58] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020;395:709-33. [PMID: 32061315 DOI: 10.1016/S0140-6736(20)30045-3] [Cited by in Crossref: 1410] [Cited by in F6Publishing: 1087] [Article Influence: 705.0] [Reference Citation Analysis]
89 Pontremoli R, Bellizzi V, Bianchi S, Bigazzi R, Cernaro V, Del Vecchio L, De Nicola L, Leoncini G, Mallamaci F, Zoccali C, Buemi M. Management of dyslipidaemia in patients with chronic kidney disease: a position paper endorsed by the Italian Society of Nephrology. J Nephrol 2020;33:417-30. [PMID: 32065354 DOI: 10.1007/s40620-020-00707-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
90 Bruyne S, Himpe J, Delanghe SE, Glorieux G, Biesen WV, Buyzere ML, Speeckaert MM, Delanghe JR. Carbamoylated Nail Proteins as Assessed by Near-Infrared Analysis are Associated with Load of Uremic Toxins and Mortality in Hemodialysis Patients. Toxins (Basel) 2020;12:E83. [PMID: 31991867 DOI: 10.3390/toxins12020083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
91 Ameh OI, Ekrikpo UE, Kengne AP. Preventing CKD in Low- and Middle-Income Countries: A Call for Urgent Action. Kidney Int Rep 2020;5:255-62. [PMID: 32154447 DOI: 10.1016/j.ekir.2019.12.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
92 Luyckx VA, Cherney DZI, Bello AK. Preventing CKD in Developed Countries. Kidney Int Rep 2020;5:263-77. [PMID: 32154448 DOI: 10.1016/j.ekir.2019.12.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
93 de Haan A, Eijgelsheim M, Vogt L, Knoers NVAM, de Borst MH. Diagnostic Yield of Next-Generation Sequencing in Patients With Chronic Kidney Disease of Unknown Etiology. Front Genet 2019;10:1264. [PMID: 31921302 DOI: 10.3389/fgene.2019.01264] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
94 Esmeijer K, Dekkers OM, de Fijter JW, Dekker FW, Hoogeveen EK. Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis. Sci Rep 2019;9:16632. [PMID: 31719617 DOI: 10.1038/s41598-019-53064-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
95 Major RW, Shepherd D, Medcalf JF, Xu G, Gray LJ, Brunskill NJ. The Kidney Failure Risk Equation for prediction of end stage renal disease in UK primary care: An external validation and clinical impact projection cohort study. PLoS Med 2019;16:e1002955. [PMID: 31693662 DOI: 10.1371/journal.pmed.1002955] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 6.7] [Reference Citation Analysis]
96 Cai Q, Dekker LH, Bakker SJL, de Borst MH, Navis G. Intraregional differences in renal function in the Northern Netherlands: The Lifelines Cohort Study. PLoS One 2019;14:e0223908. [PMID: 31613916 DOI: 10.1371/journal.pone.0223908] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Tomáš Š, Bedřich F, Josef K, Květa P, Marek B. Assessment of the degree of adherence of medical laboratories to KDIGO 2012 guideline for evaluation and management of CKD in Czechia and Slovakia. Biochem Med (Zagreb) 2019;29:030704. [PMID: 31379462 DOI: 10.11613/BM.2019.030704] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
98 Miao J, Liu J, Niu J, Zhang Y, Shen W, Luo C, Liu Y, Li C, Li H, Yang P, Liu Y, Hou FF, Zhou L. Wnt/β-catenin/RAS signaling mediates age-related renal fibrosis and is associated with mitochondrial dysfunction. Aging Cell 2019;18:e13004. [PMID: 31318148 DOI: 10.1111/acel.13004] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 24.7] [Reference Citation Analysis]
99 Castillo-Rodriguez E, Fernandez-Fernandez B, Alegre-Bellassai R, Kanbay M, Ortiz A. The chaos of hypertension guidelines for chronic kidney disease patients. Clin Kidney J 2019;12:771-7. [PMID: 31807290 DOI: 10.1093/ckj/sfz126] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
100 Wang L, Lin W, Chen J. Krüppel-like Factor 15: A Potential Therapeutic Target For Kidney Disease. Int J Biol Sci 2019;15:1955-61. [PMID: 31523196 DOI: 10.7150/ijbs.34838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
101 Olivo RE, Davenport CA, Diamantidis CJ, Bhavsar NA, Tyson CC, Hall R, Bidulescu A, Young B, Mwasongwe SE, Pendergast J, Boulware LE, Scialla JJ. Obesity and synergistic risk factors for chronic kidney disease in African American adults: the Jackson Heart Study. Nephrol Dial Transplant 2018;33:992-1001. [PMID: 28992354 DOI: 10.1093/ndt/gfx230] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
102 Delanaye P, Jager KJ, Bökenkamp A, Christensson A, Dubourg L, Eriksen BO, Gaillard F, Gambaro G, van der Giet M, Glassock RJ, Indridason OS, van Londen M, Mariat C, Melsom T, Moranne O, Nordin G, Palsson R, Pottel H, Rule AD, Schaeffner E, Taal MW, White C, Grubb A, van den Brand JAJG. CKD: A Call for an Age-Adapted Definition. J Am Soc Nephrol 2019;30:1785-805. [PMID: 31506289 DOI: 10.1681/ASN.2019030238] [Cited by in Crossref: 58] [Cited by in F6Publishing: 84] [Article Influence: 19.3] [Reference Citation Analysis]
103 Expósito C, Pera G, Rodríguez L, Arteaga I, Martínez A, Alumà A, Doladé M, Torán P, Caballeria L. Prevalence of Early Chronic Kidney Disease and Main Associated Factors in Spanish Population: Populational Study. J Clin Med 2019;8:E1384. [PMID: 31487800 DOI: 10.3390/jcm8091384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
104 Nazıroğlu M, Çiğ B, Yazğan Y, Schwaerzer GK, Theilig F, Pecze L. Albumin evokes Ca2+-induced cell oxidative stress and apoptosis through TRPM2 channel in renal collecting duct cells reduced by curcumin. Sci Rep 2019;9:12403. [PMID: 31455864 DOI: 10.1038/s41598-019-48716-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
105 Park I, Xun P, Tsinovoi CL, Klemmer P, Liu K, He K. Intakes of long-chain omega-3 polyunsaturated fatty acids and non-fried fish in relation to incidence of chronic kidney disease in young adults: a 25-year follow-up. Eur J Nutr 2020;59:399-407. [PMID: 31175412 DOI: 10.1007/s00394-019-02022-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
106 Bowe B, Xie Y, Li T, Yan Y, Xian H, Al-Aly Z. Estimates of the 2016 global burden of kidney disease attributable to ambient fine particulate matter air pollution. BMJ Open 2019;9:e022450. [PMID: 31072847 DOI: 10.1136/bmjopen-2018-022450] [Cited by in Crossref: 28] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
107 Lange T, Artelt N, Kindt F, Stracke S, Rettig R, Lendeckel U, Chadjichristos CE, Kavvadas P, Chatziantoniou C, Endlich K, Endlich N. MiR-21 is up-regulated in urinary exosomes of chronic kidney disease patients and after glomerular injury. J Cell Mol Med 2019;23:4839-43. [PMID: 31066165 DOI: 10.1111/jcmm.14317] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
108 Masoli JAH, Delgado J, Bowman K, Strain WD, Henley W, Melzer D. Association of blood pressure with clinical outcomes in older adults with chronic kidney disease. Age Ageing 2019;48:380-7. [PMID: 30824915 DOI: 10.1093/ageing/afz006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
109 Hijmans RS, van Londen M, Sarpong KA, Bakker SJL, Navis GJ, Storteboom TTR, de Jong WHA, Pol RA, van den Born J. Dermal tissue remodeling and non-osmotic sodium storage in kidney patients. J Transl Med 2019;17:88. [PMID: 30885222 DOI: 10.1186/s12967-019-1815-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
110 Bijkerk R, Au YW, Stam W, Duijs JMGJ, Koudijs A, Lievers E, Rabelink TJ, van Zonneveld AJ. Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis. Front Pharmacol 2019;10:215. [PMID: 30914951 DOI: 10.3389/fphar.2019.00215] [Cited by in Crossref: 26] [Cited by in F6Publishing: 33] [Article Influence: 8.7] [Reference Citation Analysis]
111 Sylvanus E, Sawe HR, Muhanuzi B, Mulesi E, Mfinanga JA, Weber EJ, Kilindimo S. Profile and outcome of patients with emergency complications of renal failure presenting to an urban emergency department of a tertiary hospital in Tanzania. BMC Emerg Med 2019;19:11. [PMID: 30669969 DOI: 10.1186/s12873-019-0229-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
112 Runesson B, Qureshi AR, Xu H, Gasparini A, Lindholm B, Barany P, Elinder CG, Carrero JJ. Causes of death across categories of estimated glomerular filtration rate: The Stockholm CREAtinine Measurements (SCREAM) project. PLoS One 2019;14:e0209440. [PMID: 30650090 DOI: 10.1371/journal.pone.0209440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
113 Díaz Vico T, Rodicio Miravalles JL, Sánchez Álvarez E, Moreno Gijón M, Rizzo Ramos A, Turienzo Santos EO, Sanz Álvarez L. Laparoscopic treatment of large bowel obstruction due to a self-locating peritoneal dialysis catheter. Int J Surg Case Rep 2018;53:207-10. [PMID: 30412921 DOI: 10.1016/j.ijscr.2018.10.069] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
114 Fadini GP, Solini A, Manca ML, Zatti G, Karamouzis I, Di Benedetto A, Frittitta L, Avogaro A; DARWIN-T2D Network. Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study. Acta Diabetol 2018;55:1121-9. [PMID: 30090961 DOI: 10.1007/s00592-018-1194-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
115 Gorostidi M, Sánchez-martínez M, Ruilope LM, Graciani A, de la Cruz JJ, Santamaría R, del Pino MD, Guallar-castillón P, de Álvaro F, Rodríguez-artalejo F, Banegas JR. Chronic kidney disease in Spain: Prevalence and impact of accumulation of cardiovascular risk factors. Nefrología (English Edition) 2018;38:606-15. [DOI: 10.1016/j.nefroe.2018.04.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
116 Okabayashi Y, Tsuboi N, Amano H, Miyazaki Y, Kawamura T, Ogura M, Narita I, Ninomiya T, Yokoyama H, Yokoo T. Distribution of nephrologists and regional variation in the clinical severity of IgA nephropathy at biopsy diagnosis in Japan: a cross-sectional study. BMJ Open 2018;8:e024317. [PMID: 30385449 DOI: 10.1136/bmjopen-2018-024317] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
117 Rodríguez-Ortiz ME, Pontillo C, Rodríguez M, Zürbig P, Mischak H, Ortiz A. Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease. Sci Rep 2018;8:15940. [PMID: 30374033 DOI: 10.1038/s41598-018-34386-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
118 Cañadas-Garre M, Anderson K, McGoldrick J, Maxwell AP, McKnight AJ. Genomic approaches in the search for molecular biomarkers in chronic kidney disease. J Transl Med 2018;16:292. [PMID: 30359254 DOI: 10.1186/s12967-018-1664-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
119 Tatapudi RR, Rentala S, Gullipalli P, Komarraju AL, Singh AK, Tatapudi VS, Goru KB, Bhimarasetty DM, Narni H. High Prevalence of CKD of Unknown Etiology in Uddanam, India. Kidney Int Rep 2019;4:380-9. [PMID: 30899865 DOI: 10.1016/j.ekir.2018.10.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 6.3] [Reference Citation Analysis]
120 Fouque D, Roth H, Darné B, Bouchet JL, Daugas E, Drüeke TB, Hannedouche T, Jean G, London GM. Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients. Clin Kidney J 2018;11:710-9. [PMID: 30288267 DOI: 10.1093/ckj/sfy015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
121 Hunt TV, DeMott JM, Ackerbauer KA, Whittier WL, Peksa GD. Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease. Clin Kidney J 2019;12:408-13. [PMID: 31198541 DOI: 10.1093/ckj/sfy063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
122 Drawz PE, Brown R, De Nicola L, Fujii N, Gabbai FB, Gassman J, He J, Iimuro S, Lash J, Minutolo R, Phillips RA, Rudser K, Ruilope L, Steigerwalt S, Townsend RR, Xie D, Rahman M; CRIC Study Investigators. Variations in 24-Hour BP Profiles in Cohorts of Patients with Kidney Disease around the World: The I-DARE Study. Clin J Am Soc Nephrol 2018;13:1348-57. [PMID: 29976600 DOI: 10.2215/CJN.13181117] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
123 Sawhney S, Robinson HA, van der Veer SN, Hounkpatin HO, Scale TM, Chess JA, Peek N, Marks A, Davies GI, Fraccaro P, Johnson MJ, Lyons RA, Nitsch D, Roderick PJ, Halbesma N, Miller-Hodges E, Black C, Fraser S. Acute kidney injury in the UK: a replication cohort study of the variation across three regional populations. BMJ Open 2018;8:e019435. [PMID: 29961002 DOI: 10.1136/bmjopen-2017-019435] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
124 UK HARP-III Collaborative Group. Randomized multicentre pilot study of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: United Kingdom Heart and Renal Protection (HARP)- III-rationale, trial design and baseline data. Nephrol Dial Transplant 2017;32:2043-51. [PMID: 27646835 DOI: 10.1093/ndt/gfw321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
125 Go AS, Yang J, Tan TC, Cabrera CS, Stefansson BV, Greasley PJ, Ordonez JD; Kaiser Permanente Northern California CKD Outcomes Study. Contemporary rates and predictors of fast progression of chronic kidney disease in adults with and without diabetes mellitus. BMC Nephrol 2018;19:146. [PMID: 29929484 DOI: 10.1186/s12882-018-0942-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
126 Canney M, Leahy S, Scarlett S, Kenny RA, Little MA, O'Seaghdha CM, McCrory C. Kidney Disease in Women is Associated with Disadvantaged Childhood Socioeconomic Position. Am J Nephrol 2018;47:292-9. [PMID: 29779032 DOI: 10.1159/000488362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
127 Hamada S, Gulliford MC. Multiple risk factor control, mortality and cardiovascular events in type 2 diabetes and chronic kidney disease: a population-based cohort study. BMJ Open 2018;8:e019950. [PMID: 29739781 DOI: 10.1136/bmjopen-2017-019950] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
128 Koye DN, Magliano DJ, Nelson RG, Pavkov ME. The Global Epidemiology of Diabetes and Kidney Disease. Adv Chronic Kidney Dis 2018;25:121-32. [PMID: 29580576 DOI: 10.1053/j.ackd.2017.10.011] [Cited by in Crossref: 160] [Cited by in F6Publishing: 134] [Article Influence: 40.0] [Reference Citation Analysis]
129 Xu X, Nie S, Ding H, Hou FF. Environmental pollution and kidney diseases. Nat Rev Nephrol 2018;14:313-24. [PMID: 29479079 DOI: 10.1038/nrneph.2018.11] [Cited by in Crossref: 95] [Cited by in F6Publishing: 138] [Article Influence: 23.8] [Reference Citation Analysis]
130 Fernandez-Prado R, Fernandez-Fernandez B, Ortiz A. Women and renal replacement therapy in Europe: lower incidence, equal access to transplantation, longer survival than men. Clin Kidney J 2018;11:1-6. [PMID: 29423194 DOI: 10.1093/ckj/sfx154] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
131 Evans M, Grams ME, Sang Y, Astor BC, Blankestijn PJ, Brunskill NJ, Collins JF, Kalra PA, Kovesdy CP, Levin A, Mark PB, Moranne O, Rao P, Rios PG, Schneider MP, Shalev V, Zhang H, Chang AR, Gansevoort RT, Matsushita K, Zhang L, Eckardt KU, Hemmelgarn B, Wheeler DC. Risk Factors for Prognosis in Patients With Severely Decreased GFR. Kidney Int Rep 2018;3:625-37. [PMID: 29854970 DOI: 10.1016/j.ekir.2018.01.002] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
132 Abd ElHafeez S, Bolignano D, D'Arrigo G, Dounousi E, Tripepi G, Zoccali C. Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review. BMJ Open 2018;8:e015069. [PMID: 29326180 DOI: 10.1136/bmjopen-2016-015069] [Cited by in Crossref: 43] [Cited by in F6Publishing: 49] [Article Influence: 10.8] [Reference Citation Analysis]
133 Alkerwi A, Sauvageot N, El Bahi I, Delagardelle C, Beissel J, Noppe S, Roderick PJ, Mindell JS, Stranges S. Prevalence and related risk factors of chronic kidney disease among adults in Luxembourg: evidence from the observation of cardiovascular risk factors (ORISCAV-LUX) study. BMC Nephrol 2017;18:358. [PMID: 29221436 DOI: 10.1186/s12882-017-0772-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
134 Krata N, Zagożdżon R, Foroncewicz B, Mucha K. Oxidative Stress in Kidney Diseases: The Cause or the Consequence? Arch Immunol Ther Exp (Warsz) 2018;66:211-20. [PMID: 29214330 DOI: 10.1007/s00005-017-0496-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 7.4] [Reference Citation Analysis]
135 Trocchi P, Girndt M, Scheidt-Nave C, Markau S, Stang A. Impact of the estimation equation for GFR on population-based prevalence estimates of kidney dysfunction. BMC Nephrol 2017;18:341. [PMID: 29183273 DOI: 10.1186/s12882-017-0749-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
136 Kesztyüs T, Simonsmeier U, Kesztyüs D. Developing a classification system for haemoglobin management in patients with end-stage renal disease on haemodialysis: a secondary data analysis. BMJ Open 2017;7:e017423. [PMID: 29122793 DOI: 10.1136/bmjopen-2017-017423] [Reference Citation Analysis]
137 Wagner M, Wanner C, Schich M, Kotseva K, Wood D, Hartmann K, Fette G, Rücker V, Oezkur M, Störk S, Heuschmann PU. Patient's and physician's awareness of kidney disease in coronary heart disease patients - a cross-sectional analysis of the German subset of the EUROASPIRE IV survey. BMC Nephrol 2017;18:321. [PMID: 29070030 DOI: 10.1186/s12882-017-0730-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
138 Coresh J, Hu JR, Bello AK, Feldman HI, Fogo AB, Ganji MR, Harris DC, Levey AS, Okpechi IG, Stengel B, Thomas B, Wiecek A, Gansevoort RT. Action plan for determining and monitoring the prevalence of chronic kidney disease. Kidney Int Suppl (2011) 2017;7:63-70. [PMID: 30675421 DOI: 10.1016/j.kisu.2017.07.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
139 Lange T, Stracke S, Rettig R, Lendeckel U, Kuhn J, Schlüter R, Rippe V, Endlich K, Endlich N. Identification of miR-16 as an endogenous reference gene for the normalization of urinary exosomal miRNA expression data from CKD patients. PLoS One 2017;12:e0183435. [PMID: 28859135 DOI: 10.1371/journal.pone.0183435] [Cited by in Crossref: 38] [Cited by in F6Publishing: 54] [Article Influence: 7.6] [Reference Citation Analysis]
140 Delanghe S, Delanghe JR, Speeckaert R, Van Biesen W, Speeckaert MM. Mechanisms and consequences of carbamoylation. Nat Rev Nephrol 2017;13:580-93. [PMID: 28757635 DOI: 10.1038/nrneph.2017.103] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]
141 Murkamilov IT, Aitbaev KA, Fomin VV. [Gender features of cardiovascular events in patients with chronic glomerulonephritis at the pre-dialysis stage of the disease]. Ter Arkh 2017;89:56-61. [PMID: 28745690 DOI: 10.17116/terarkh201789656-61] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
142 Du Y, Zhang S, Hu M, Wang Q, Shen H, Zhang Y, Yan D, Li Y, Zhang M, Meng Q. Prevalence of chronic kidney disease markers: Evidence from a three-million married population with fertility desire in rural China. Sci Rep 2017;7:2710. [PMID: 28578426 DOI: 10.1038/s41598-017-02355-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
143 Fernandez-Prado R, Esteras R, Perez-Gomez MV, Gracia-Iguacel C, Gonzalez-Parra E, Sanz AB, Ortiz A, Sanchez-Niño MD. Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease. Nutrients 2017;9:E489. [PMID: 28498348 DOI: 10.3390/nu9050489] [Cited by in Crossref: 43] [Cited by in F6Publishing: 52] [Article Influence: 8.6] [Reference Citation Analysis]
144 Čabarkapa V, Ilinčić B, Đerić M, Radosavkić I, Šipovac M, Sudji J, Petrović V. Screening for Chronic Kidney Disease in Adult Males in Vojvodina: A Cross-sectional Study. J Med Biochem 2017;36:153-62. [PMID: 28680359 DOI: 10.1515/jomb-2017-0006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
145 Coresh J. Update on the Burden of CKD. J Am Soc Nephrol 2017;28:1020-2. [PMID: 28302756 DOI: 10.1681/ASN.2016121374] [Cited by in Crossref: 60] [Cited by in F6Publishing: 78] [Article Influence: 12.0] [Reference Citation Analysis]
146 Jankowska M, Rutkowski B, Dębska-Ślizień A. Vitamins and Microelement Bioavailability in Different Stages of Chronic Kidney Disease. Nutrients 2017;9:E282. [PMID: 28294976 DOI: 10.3390/nu9030282] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
147 Markó L, Mannaa M, Haschler TN, Krämer S, Gollasch M. Renoprotection: focus on TRPV1, TRPV4, TRPC6 and TRPM2. Acta Physiol (Oxf) 2017;219:589-612. [PMID: 28028935 DOI: 10.1111/apha.12828] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
148 Delanaye P, Glassock RJ, De Broe ME. Epidemiology of chronic kidney disease: think (at least) twice! Clin Kidney J 2017;10:370-4. [PMID: 28617483 DOI: 10.1093/ckj/sfw154] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
149 Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13:104-114. [PMID: 27941934 DOI: 10.1038/nrneph.2016.163] [Cited by in Crossref: 128] [Cited by in F6Publishing: 168] [Article Influence: 21.3] [Reference Citation Analysis]
150 Jesky MD, Dutton M, Dasgupta I, Yadav P, Ng KP, Fenton A, Kyte D, Ferro CJ, Calvert M, Cockwell P, Stringer SJ. Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study. PLoS One 2016;11:e0165675. [PMID: 27832126 DOI: 10.1371/journal.pone.0165675] [Cited by in Crossref: 18] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
151 Seibert E, Zohles K, Ulrich C, Kluttig A, Nuding S, Kors JA, Swenne CA, Werdan K, Fiedler R, Girndt M. Association between autonomic nervous dysfunction and cellular inflammation in end-stage renal disease. BMC Cardiovasc Disord 2016;16:210. [PMID: 27809785 DOI: 10.1186/s12872-016-0385-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
152 Stryckers M, Nagler EV, Van Biesen W. The Need for Accurate Risk Prediction Models for Road Mapping, Shared Decision Making and Care Planning for the Elderly with Advanced Chronic Kidney Disease. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 2016;37:33-42. [PMID: 27883315 DOI: 10.1515/prilozi-2016-0014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
153 Gasparini A, Evans M, Coresh J, Grams ME, Norin O, Qureshi AR, Runesson B, Barany P, Ärnlöv J, Jernberg T, Wettermark B, Elinder CG, Carrero JJ. Prevalence and recognition of chronic kidney disease in Stockholm healthcare. Nephrol Dial Transplant 2016;31:2086-94. [PMID: 27738231 DOI: 10.1093/ndt/gfw354] [Cited by in Crossref: 58] [Cited by in F6Publishing: 71] [Article Influence: 9.7] [Reference Citation Analysis]
154 Turchetti G, Bellelli S, Amato M, Bianchi S, Conti P, Cupisti A, Panichi V, Rosati A, Pizzarelli F; On Behalf of the Tuscany CKD Study Group. The social cost of chronic kidney disease in Italy. Eur J Health Econ 2017;18:847-58. [PMID: 27699568 DOI: 10.1007/s10198-016-0830-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
155 Delanaye P, Melsom T, Ebert N, Bäck SE, Mariat C, Cavalier E, Björk J, Christensson A, Nyman U, Porrini E, Remuzzi G, Ruggenenti P, Schaeffner E, Soveri I, Sterner G, Eriksen BO, Gaspari F. Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: a review. Part 2: Why to measure glomerular filtration rate with iohexol? Clin Kidney J 2016;9:700-4. [PMID: 27679716 DOI: 10.1093/ckj/sfw071] [Cited by in Crossref: 64] [Cited by in F6Publishing: 71] [Article Influence: 10.7] [Reference Citation Analysis]
156 Mihai S, Codrici E, Popescu ID, Enciu AM, Rusu E, Zilisteanu D, Albulescu R, Anton G, Tanase C. Proteomic Biomarkers Panel: New Insights in Chronic Kidney Disease. Dis Markers. 2016;2016:3185232. [PMID: 27667892 DOI: 10.1155/2016/3185232] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
157 Dienemann T, Fujii N, Orlandi P, Nessel L, Furth SL, Hoy WE, Matsuo S, Mayer G, Methven S, Schaefer F, Schaeffner ES, Solá L, Stengel B, Wanner C, Zhang L, Levin A, Eckardt KU, Feldman HI. International Network of Chronic Kidney Disease cohort studies (iNET-CKD): a global network of chronic kidney disease cohorts. BMC Nephrol 2016;17:121. [PMID: 27590182 DOI: 10.1186/s12882-016-0335-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
158 Bowe B, Xie Y, Xian H, Lian M, Al-Aly Z. Geographic Variation and US County Characteristics Associated With Rapid Kidney Function Decline. Kidney Int Rep 2017;2:5-17. [PMID: 29142937 DOI: 10.1016/j.ekir.2016.08.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 4.8] [Reference Citation Analysis]
159 Melloni C, Alexander KP. Exploring the Nexus Between Chronic Kidney Disease and Cardiovascular Disease. Eur Heart J Qual Care Clin Outcomes 2016;2:62-3. [PMID: 29474629 DOI: 10.1093/ehjqcco/qcw009] [Reference Citation Analysis]
160 Abitbol CL, Moxey-Mims M. Chronic kidney disease: Low birth weight and the global burden of kidney disease. Nat Rev Nephrol 2016;12:199-200. [PMID: 26898625 DOI: 10.1038/nrneph.2016.19] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
161 Black C, van der Veer SN. Unlocking the Value of Variation in CKD Prevalence. J Am Soc Nephrol 2016;27:1874-7. [PMID: 26714870 DOI: 10.1681/ASN.2015111280] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]